期刊文献+

洛匹那韦的合成 被引量:2

Synthesis of lopinavir
下载PDF
导出
摘要 目的研究抗病毒药物洛匹那韦的合成。方法以(2S,3S,5S)-5-(叔丁氧羰基)氨基-2-氨基-3-羟基-1,6-二苯基己烷为起始原料,与2,6-二甲基苯氧乙酸经肽键缩合、脱保护、最终与(2S)-(1-四氢嘧啶-2-酮)-3-甲基丁酸再经肽键缩合制备目标产物洛匹那韦。结果三步合成了目标产物洛匹那韦,以BDC计,总收率为50.7%,通过1H-NMR、MS、确定了结构。结论该方法简单,后处理方便,副产物较少,适合工业化生产。 Objective To prepare antiviral drugs lopinavir. Methods Lopinavir was synthesized from ( 2S, 3S, 5 S) -5-tert-Butyloxycar- bonylamino-2-amino-3-hydroxy-1,6-diphenylhexane reaction with 2,6-Dimethylphenoxyacetic acid by condensation deprotection,which was subjected to condensation with (2S) -( 1-Tetrahydropyramid-2-one)-3-methylbutanoic acid. Results The target product was synthe- sized via three-step procedure starting from BDC in a total yield of 50.7% and its structure was confirmed by 1 H-NMR, ESI-MS. Conclu- sions The method of preparation is much easier to perform,with simple work-up and fewer by-products. It is suitable for industrial pro-
出处 《安徽医药》 CAS 2013年第12期2026-2027,共2页 Anhui Medical and Pharmaceutical Journal
关键词 抗病毒 洛匹那韦 化学合成 antiviral drugs lopinavir synthesis
  • 相关文献

参考文献11

  • 1Hasson H,Galli L,Gallotta G. HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment:a randomised pilot study(KaMon)[J].{H}New Microbiologica,2012,(04):469-474.
  • 2Cooper C,la-Porte C,Tossonian H. A pilot,prospective,open-label simplification study to evaluate the safety,efficacy,and pharmacokinetics of once-daily lopinavir-ritonavir monotherapy in HIV-HCV coinfected patients:the MONOCO study[J].{H}HIV CLINICAL TRIALS,2012,(04):179-188.
  • 3Lambert-Niclot S,Masquelier B,Cohen Codar I. Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice[J].{H}Journal of Antimicrobial Chemotherapy,2012,(10):2487-2493.
  • 4Josephson F,Andersson MC,Flamholc L. The relation between treatment outcome and efavirenz,atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patients[J].{H}EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,2010,(04):349-357.
  • 5姚亚敏,沐俊,孙骥,马芳,卢洪洲,张丽军.洛匹那韦药代动力学的研究进展[J].药学实践杂志,2012,30(5):336-339. 被引量:11
  • 6姚亚敏,孙建军,陈军,刘晓茜,卢洪洲,张丽军.LC-MS/MS法同时测定洛匹那韦和利托那韦的血浆浓度[J].药学学报,2010,45(2):279-282. 被引量:12
  • 7代玉英,梅晓冬.洛匹那韦逆转LLC/cMOAT细胞多药耐药的作用[J].安徽医药,2010,14(11):1263-1265. 被引量:1
  • 8何勇;陈仕云;余三喜.利托那韦异构体杂质的合成研究及控制方法[P]中国:102786494,2012.
  • 9邬皓,李家明,盛日正,周鹏,钟国琛,蒋丽娜.川芎嗪芳酸醚甘氨酸衍生物合成及抗血小板聚集活性[J].安徽医药,2011,15(8):937-940. 被引量:3
  • 10何勇,陈仕云,吴宗好.瑞格列奈的合成[J].中国医药工业杂志,2012,43(2):84-86. 被引量:5

二级参考文献39

  • 1姜丹.急性缺血性脑血管病早期诊断和对策[J].安徽医药,2005,9(8):624-626. 被引量:12
  • 2霍勇,孟磊,温绍君,李家增.抗血小板药物在动脉血栓栓塞性疾病中的合理应用[J].中华内科杂志,2006,45(4):347-348. 被引量:19
  • 3甘后军.抗血小板药物联合治疗在缺血性脑血管病中的应用[J].安徽医药,2006,10(5):368-370. 被引量:4
  • 4Ford JM,Hait WN.Pharmacologic circumvention of multidrug resistance[J].Cytotechnology,1993,12:171-212.
  • 5Ramalingam S,Belani CP.Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancer[J].Semin Thorac Cardiovasc Surg,2003,15(4):437-8.
  • 6Katragadda S,Budda B,Anand BS,et al.Role of efflux pumps and metabolizing enzymes in drug delivery[J].Expert Opin Drug Deliv,2005,2(4):683-705.
  • 7El-Sheikh AA,Heuvel JJ,Koenderink JB,et al.Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP)2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport[J].Pharmacol Exp Ther,2007,320(1):229-35.
  • 8Okumura H,Chen ZS,Sakou M,et al.Reversal of P-Glycoprotein and Multidrug-Resistance Protein-Mediated Drug Resistance in KB Cells by 5-O-benzoylated taxinine K[J].Mol Pharmacol,2000,58:1563-9.
  • 9Eilers M,Roy U,Mondal D.MRP (ABCC) transporters-mediated efflux of anti-HIV drugs,saquinavir and zidovudine,from human endothelial cells[J].Exp Biol Med(Maywood),2008,233(9):1149-60.
  • 10Janneh O,Jones E,Chandler B,et al.Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes[J].Antimicrob Chemother,2007,60:987-93.

共引文献29

同被引文献24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部